These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. CXCL10 treatment promotes reduction of IL-10 Eufrásio de Figueiredo WM; Heredia FF; Santos AS; da Rocha Braga R; Marciano Fonseca FR; Lúcia de Castro Rodrigues N; Abreu TM; Maria de Lima Pompeu M; Barbosa HS; Teixeira MJ Exp Parasitol; 2019 Dec; 207():107789. PubMed ID: 31669169 [TBL] [Abstract][Full Text] [Related]
4. Influence of the host and parasite strain in a mouse model of visceral Leishmania infantum infection. Honoré S; Garin YJ; Sulahian A; Gangneux JP; Derouin F FEMS Immunol Med Microbiol; 1998 Jul; 21(3):231-9. PubMed ID: 9718213 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis. de Jesus Pereira NC; Régis WC; Costa LE; de Oliveira JS; da Silva AG; Martins VT; Duarte MC; de Souza JR; Lage PS; Schneider MS; Melo MN; Soto M; Soares SA; Tavares CA; Chávez-Fumagalli MA; Coelho EA Exp Parasitol; 2015 Jun; 153():180-90. PubMed ID: 25845753 [TBL] [Abstract][Full Text] [Related]
6. Protection mediated by chemokine CXCL10 in BALB/c mice infected by Leishmania infantum. Figueiredo WME; Viana SM; Alves DT; Guerra PV; Coêlho ZCB; Barbosa HS; Teixeira MJ Mem Inst Oswaldo Cruz; 2017 Aug; 112(8):561-568. PubMed ID: 28767981 [TBL] [Abstract][Full Text] [Related]
7. Phenotypical Characterization of Spleen Remodeling in Murine Experimental Visceral Leishmaniasis. de Melo CVB; Hermida MD; Mesquita BR; Fontes JLM; Koning JJ; Solcà MDS; Benevides BB; Mota GBS; Freitas LAR; Mebius RE; Dos-Santos WLC Front Immunol; 2020; 11():653. PubMed ID: 32351510 [No Abstract] [Full Text] [Related]
8. Studies in a co-infection murine model of Plasmodium chabaudi chabaudi and Leishmania infantum: interferon-gamma and interleukin-4 mRNA expression. Marques CS; Rolão N; Centeno-Lima S; Lousada H; Maia C; Campino L; do Rosário VE; Silveira H Mem Inst Oswaldo Cruz; 2005 Dec; 100(8):889-92. PubMed ID: 16444421 [TBL] [Abstract][Full Text] [Related]
9. T-cell populations and cytokine expression are impaired in thymus and spleen of protein malnourished BALB/c mice infected with Leishmania infantum. Cuervo-Escobar S; Losada-Barragán M; Umaña-Pérez A; Porrozzi R; Saboia-Vahia L; Miranda LH; Morgado FN; Menezes RC; Sánchez-Gómez M; Cuervo P PLoS One; 2014; 9(12):e114584. PubMed ID: 25535967 [TBL] [Abstract][Full Text] [Related]
10. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice. Mazumdar T; Anam K; Ali N Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644 [TBL] [Abstract][Full Text] [Related]
12. Human Interleukin-32γ Plays a Protective Role in an Experimental Model of Visceral Leishmaniasis in Mice. Gomes RS; Silva MVT; Dos Santos JC; van Linge C; Reis JM; Teixeira MM; Pinto SA; Dorta ML; Bai X; Chan ED; Dinarello CA; Oliveira MAP; Joosten LAB; Ribeiro-Dias F Infect Immun; 2018 May; 86(5):. PubMed ID: 29483288 [TBL] [Abstract][Full Text] [Related]
13. Serum amyloid A levels and alpha 2 and gamma globulins on serum protein electrophoresis in cats exposed to and infected with Leishmania infantum. Savioli G; Archer J; Brianti E; Benelli G; Schnyder M; Iatta R; Otranto D; Cantacessi C Parasit Vectors; 2021 Apr; 14(1):217. PubMed ID: 33883004 [TBL] [Abstract][Full Text] [Related]